Distinct Role of STAT3 and STAT5 Factors in MDS and AML

被引：1
|
作者：
Fasouli, Eirini Sofia [1 ]
Giavi, Konstantina [1 ]
Makri, Charikleia [1 ]
Bystrykh, Leonid [2 ]
Bouchla, Anthi [3 ]
Athanasiadis, Emmanouil [1 ]
Vatsellas, Giannis [1 ]
Pappa, Vasiliki [4 ,5 ]
Katsantoni, Eleni [6 ]
机构：
[1] Acad Athens, Biomed Res Fdn, Basic Res Ctr, Athens, Greece
[2] Univ Groningen, UMCG, Groningen, Netherlands
[3] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 2, Hematol Unit,Propaedeut & Res Unit,Sch Med, Athens, Greece
[4] Natl & Kapodistrian Univ Athens, Univ Gen Hosp Attikon, Dept Internal Med 2, Med Sch, Athens, Greece
[5] Natl & Kapodistrian Univ Athens, Univ Gen Hosp Attikon, Res Inst, Hematol Unit, Athens, Greece
[6] Acad Athens, Biomed Res Fdn, Athens, Greece
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-185823
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] STAT5 and STAT5 Inhibitors in Hematological Malignancies
    Tolomeo, Manlio
    Meli, Maria
    Grimaudo, Stefania
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (17) : 2036 - 2046
  • [42] Thrombopoietin induces association of Crk1 with STAT5 but not STAT3 in human platelets
    Ozaki, K
    Oda, A
    Wakao, H
    Rhodes, J
    Druker, BJ
    Ishida, A
    Wakui, M
    Okamoto, S
    Morita, K
    Handa, M
    Komatsu, N
    Ohashi, H
    Miyajima, A
    Ikeda, Y
    BLOOD, 1998, 92 (12) : 4652 - 4662
  • [43] Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
    Wingelhofer, Bettina
    Neubauer, Heidi A.
    Valent, Peter
    Han, Xiaonan
    Constantinescu, Stefan N.
    Gunning, Patrick T.
    Mueller, Mathias
    Moriggl, Richard
    LEUKEMIA, 2018, 32 (08) : 1713 - 1726
  • [44] PDGFRβ DRIVES PROGRESSION BY ONCOGENE TRANSCRIPTION THROUGH STAT3/STAT5 HYPERACTIVATION IN ALCL
    Alonso, I. Garces de los Fayos
    Zujo, L.
    Krsmanovic, I.
    Kodojova, P.
    Schlederer, M.
    Timelthaler, G.
    Edtmayer, S.
    Giordano, C.
    Kothmayer, M.
    Neubauer, H. A.
    Dey, S.
    Pusch, O.
    Hogler, S.
    Tangermann, S.
    Schiefer, A.
    Kornauth, C.
    Stoiber, P. Wolf D.
    Staber, P.
    Klapper, W.
    Woessmann, W.
    Gunning, P.
    Turner, S.
    Moriggl, R.
    Lagger, S.
    Kenner, L.
    LEUKEMIA RESEARCH, 2022, 121 : S69 - S69
  • [45] STAT3 Activity and Function in Cancer: Modulation by STAT5 and miR-146b
    Walker, Sarah
    Xiang, Michael
    Frank, David
    CANCERS, 2014, 6 (02): : 958 - 968
  • [46] The functional interplay between activated Stat5 and Stat3 in breast cancer formation and progression
    Vafaizadeh, Vida
    Groner, Bernd
    CANCER RESEARCH, 2013, 73 (08)
  • [47] Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy
    Verdeil, Gregory
    Lawrence, Toby
    Schmitt-Verhulst, Anne-Marie
    Auphan-Anezin, Nathalie
    CANCERS, 2019, 11 (12)
  • [48] Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
    Bettina Wingelhofer
    Heidi A. Neubauer
    Peter Valent
    Xiaonan Han
    Stefan N. Constantinescu
    Patrick T. Gunning
    Mathias Müller
    Richard Moriggl
    Leukemia, 2018, 32 : 1713 - 1726
  • [49] Age-associated myeloid malignancies - the role of STAT3 and STAT5 in myelodysplastic syndrome and acute myeloid leukemia
    Fasouli, Eirini Sofia
    Katsantoni, Eleni
    FEBS LETTERS, 2024, 598 (22) : 2809 - 2828
  • [50] 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
    Temple, Alexandra Elizabeth
    Walker, Sarah R.
    CANCER RESEARCH, 2024, 84 (06)
12345